Empagliflozin does not affect left ventricular diastolic function in patients with type 2 diabetes mellitus and coronary artery disease: insight from the EMPA-HEART CardioLink-6 randomized clinical trial

Authors :: Archana Rai
Kim A. Connelly
Subodh Verma
C. David Mazer
Hwee Teoh
Ming-Yen Ng
Idan Roifman
Adrian Quan
Marina Pourafkari
Laura Jimenez-Juan
Venkat Ramanan
Yin Ge
Djeven P. Deva
Andrew T. Yan
Source :: Acta diabetologica. 59(4)
Publication Year :: 2021

Subjects :: Endocrinology
Diabetes Mellitus, Type 2
Glucosides
Endocrinology, Diabetes and Metabolism
Internal Medicine
Humans
General Medicine
Coronary Artery Disease
Benzhydryl Compounds
Ventricular Function, Left

Tools